Quaker Chemical (KWR) Valuation Check As New US$250 Million Buyback And Board Changes Take Shape

Quaker Chemical (KWR) has put fresh attention on its stock after announcing a new share repurchase program of up to US$250 million, alongside board changes including a new Chairman and a smaller board.

See our latest analysis for Quaker Chemical.

The share repurchase news and board changes follow a mixed price pattern: the share price is up 1.95% in the last day and 4.09% over the week, but down 10.40% over 90 days. The 1-year total shareholder return of 35.24% contrasts with weaker total shareholder returns over 3 and 5 years, suggesting that recent momentum has picked up from a softer longer term record.

If this kind of governance and capital allocation update has your attention, it can also be useful to see which other companies are drawing interest, starting with 20 top founder-led companies

With Quaker Chemical trading at US$141.84 and a consensus price target of US$169.50, plus fresh buyback and governance moves, is the stock still undervalued at this level or already pricing in stronger future growth?

Most Popular Narrative: 22.5% Undervalued

At $141.84, the most followed narrative pegs Quaker Chemical’s fair value at $183, which frames the new buyback plan against a richer implied upside.

Quaker is seeing double-digit volume growth in its advanced and specialty solutions product line, tied to rising demand for high-performance, sustainable chemistries that support manufacturing automation, energy storage/battery production, and greener industrial processes. This boosts both revenue growth and supports higher margins as product mix shifts favorably.

Read the complete narrative.

Curious what kind of revenue path and margin profile would need to materialize for that higher fair value to hold up, and how much earnings power that implies over time.

Result: Fair Value of $183 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, there are still clear pressure points, including higher raw material costs and elevated net leverage. These factors could restrain margins and limit flexibility for further buybacks.

Find out about the key risks to this Quaker Chemical narrative.

Another Way to Look at Value

Analysts framing Quaker Chemical as 22.5% undervalued on a fair value of $183 are taking a different view to the SWS DCF model, which points to a future cash flow value of $108.01 and suggests the stock is trading above that level. Which set of assumptions do you find more convincing?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Quaker Chemical for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 48 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With both risks and rewards in play, do you feel the balance suits your own risk tolerance and time horizon, or not quite yet? Take a closer look at the 1 key reward and 4 important warning signs

Looking for more investment ideas?

If Quaker Chemical has sharpened your thinking, do not stop here. Broaden your opportunity set with focused stock ideas built from clear fundamentals and disciplined filters.

• Target potential mispricings by scanning for quality companies that still look cheap using the 48 high quality undervalued stocks.
• Prioritize resilience by reviewing the 69 resilient stocks with low risk scores so you can focus on stocks with steadier risk profiles.
• Hunt for lesser known opportunities through the screener containing 21 high quality undiscovered gems before the wider market pays attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com